Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for dendritic cell-based immunotherapy

Compositions and methods for dendritic cell-based immunotherapy

US Patent 7659117 · Granted Feb 9, 2010

Estimated economic value: $167,750,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions employing alternative reading frame polypeptides for the treatment 2015
Compositions employing alternative reading frame polypeptides for the treatment 2015
Compositions employing alternative reading frame polypeptides for the treatment 2015
Modified human interferon-beta polypeptides2013
Compositions and methods for the treatment of disease associated with TRP-P8 exp2013
Compositions and methods for the treatment of disease associated with TRP-P8 exp2013
Use of MVA to treat prostate cancer2013
Compositions and methods for the treatment of disease associated with Trp-p8 exp2013
Compositions and methods for the treatment of disease associated with Trp-p8 exp2013
HLA-DR specific antibodies, compositions and methods2013
HLA-DR specific antibodies, compositions and methods2013
Methods for treating cancer with a recombinant MVA expressing HER-22012